CILAG AG (Switzerland) holds 4 active US FDA Type II Drug Master Files and 20 inactive and has DMF or CEP filings on record for 18 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “CILAG AG: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cilag-ag

Overview

CILAG AG is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering ALCAFTADINE (R89674) DRUG SUBSTANCE; CLADRIBINE DRUG SUBSTANCE; IRON SUCROSE DRUG SUBSTANCE; REMIFENTANIL HCL DRUG SUBSTANCE.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which CILAG AG holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

CILAG AG holds 4 active (24 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • REMIFENTANIL HCL DRUG SUBSTANCEActive2013-09-06
  • ALCAFTADINE (R89674) DRUG SUBSTANCEActive2006-12-21
  • IRON SUCROSE DRUG SUBSTANCEActive2006-06-26
  • CLADRIBINE DRUG SUBSTANCEActive2004-08-16
  • FOSPHENYTOIN SODIUM DRUG SUBSTANCE (A PHARMACEUTICAL INGREDIENT)Inactive2005-11-14
  • SODIUM FERRIC GLUCONATEInactive2004-08-13
  • DIVALPROEX SODIUMInactive2002-11-05
  • DOXAZOSIN MESYLATEInactive1999-06-03
  • TERAZOSIN HYDROCHLORIDE MONOHYDRATEInactive1997-09-08
  • CLADRIBINEInactive1996-11-21
  • FLUOXETINE HYDROCHORIDEInactive1996-11-15
  • BUPROPION HYDROCHLORIDEInactive1996-08-12
  • OXAPROZINInactive1996-02-28
  • KETOROLAC TROMETHAMINEInactive1996-01-04
  • RETINAMIDIC ACIDInactive1995-07-13
  • IRI -695Inactive1994-11-08
  • TOPIRAMATEInactive1994-07-08
  • RIMANTADINE HYDROCHLORIDEInactive1993-05-05
  • 2-BENZYLAMINO-PYRIDINEInactive1990-10-31
  • TERFENADINEInactive1990-01-25
  • CYCLOBENZAPRINE HCLInactive1989-06-08
  • MOLINDONE HYDROCHLORIDEInactive1989-03-21
  • SUCCIMERInactive1989-02-24
  • NDC 12502 - 1819 METHIMAZOLEInactive1979-08-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CILAG AG in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this CILAG AG?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.